Human in vivo study of the renin-angiotensin-aldosterone system and the sympathetic activity after 8 weeks daily intake of fermented milk

Clinical Physiology and Functional Imaging

Volumn 30, Issue 2, 2010, Pages 162-168

  Usinger, Lotte ^a   Ibsen, Hans ^b   Linneberg, Allan ^c   Azizi, Michel ^d   Flambard, Bénédicte ^e   Jensen, Lars T ^a  

^a Glostrup University Hospital Glostrup   (Denmark)

^b HOLBÆK HOSPITAL   (Denmark)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e CHR HANSEN A S   (Denmark)

Author keywords

Angiotensin converting enzyme; Blood pressure; Hypertension; Lactobacillus helveticus; Noradrenaline; Sympathetic nervous system; Tilt table test

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; NORADRENALIN; PLACEBO; RENIN;

ADRENERGIC ACTIVITY; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BORDERLINE HYPERTENSION; CARDIOVASCULAR RESPONSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DOUBLE BLIND PROCEDURE; FEMALE; FERMENTATION; FOOD INTAKE; HEART RATE; HUMAN; IN VIVO STUDY; LACTOBACILLUS HELVETICUS; MAJOR CLINICAL STUDY; MALE; MILK; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT DURATION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CULTURED MILK PRODUCTS; FEMALE; HUMANS; HYPERTENSION; LACTOBACILLUS HELVETICUS; MALE; MIDDLE AGED; MILK PROTEINS; NOREPINEPHRINE; PEPTIDES; RENIN-ANGIOTENSIN SYSTEM; SYMPATHETIC NERVOUS SYSTEM; TILT-TABLE TEST;

EID: 76949096018     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2009.00921.x     Document Type: Article

References (34)

1. Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. J Am Coll Nutr 2005, 24:257-265.
2. Azizi M, Rousseau A, Ezan E, Guyene TT, Michelet S, Grognet JM, Lenfant M, Corvol P, Menard J. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest 1996, 97:839-844.
3. Azizi M, Ezan E, Nicolet L, Grognet JM, Menard J. High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: a new marker of chronic angiotensin-converting enzyme inhibition. Hypertension 1997, 30:1015-1019.
4. Engberink MF, Schouten EG, Kok FJ, van Mierlo LA, Brouwer IA, Geleijnse JM. Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial. Hypertension 2008, 51:399-405.
5. Esler M. The sympathetic system and hypertension. Am J Hypertens 2000, 13:99S-105S.
6. Flaa A, Mundal HH, Eide I, Kjeldsen S, Rostrup M. Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges. Hypertension 2006, 47:396-402.
7. Foltz M, Meynen EE, Bianco V, van PC, Koning TM, Kloek J. Angiotensin converting enzyme inhibitory peptides from a lactotripeptide-enriched milk beverage are absorbed intact into the circulation. J Nutr 2007, 137:953-958.
8. Fuglsang A, Nilsson D, Nyborg NC. Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently catheterized, spontaneously hypertensive rats. Appl Environ Microbiol 2002, 68:3566-3569.
9. Fuglsang A, Rattray FP, Nilsson D, Nyborg NC. Lactic acid bacteria: inhibition of angiotensin converting enzyme in vitro and in vivo. Antonie Van Leeuwenhoek 2003, 83:27-34.
10. Furlan R, Porta A, Costa F, Tank J, Baker L, Schiavi R, Robertson D, Malliani A, Mosqueda-Garcia R. Oscillatory patterns in sympathetic neural discharge and cardiovascular variables during orthostatic stimulus. Circulation 2000, 101:886-892.
11. Geelen G, Laitinen T, Hartikainen J, Lansimies E, Bergstrom K, Niskanen L. Gender influence on vasoactive hormones at rest and during a 70 degrees head-up tilt in healthy humans. J Appl Physiol 2002, 92:1401-1408.
12. Hayakawa K, Kimura M, Kamata K. Mechanism underlying gamma-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats. Eur J Pharmacol 2002, 438:107-113.
13. Hayakawa K, Kimura M, Kasaha K, Matsumoto K, Sansawa H, Yamori Y. Effect of a gamma-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Nutr 2004, 92:411-417.
14. Inoue K, Shirai T, Ochiai H, Kasao M, Hayakawa K, Kimura M, Sansawa H. Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr 2003, 57:490-495.
15. Jansen RW, Lenders JW, Thien T, Hoefnagels WH. The influence of age and blood pressure on the hemodynamic and humoral response to head-up tilt. J Am Geriatr Soc 1989, 37:528-532.
16. Jauhiainen T, Vapaatalo H, Poussa T, Kyronpalo S, Rasmussen M, Korpela R. Lactobacillus helveticus fermented milk lowers blood pressure in hypertensive subjects in 24-h ambulatory blood pressure measurement. Am J Hypertens 2005, 18:1600-1605.
17. Kawase M, Hashimoto H, Hosoda M, Morita H, Hosono A. Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J Dairy Sci 2000, 83:255-263.
18. Maeno M, Yamamoto N, Takano T. Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790. J Dairy Sci 1996, 79:1316-1321.
19. Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr 1996, 126:3063-3068.
20. Meisel H. Multifunctional peptides encrypted in milk proteins. Biofactors 2004, 21:55-61.
21. Meisel H, FitzGerald RJ. Opioid peptides encrypted in intact milk protein sequences. Br J Nutr 2000, 84(Suppl 1):S27-S31.
22. Meredith IT, Eisenhofer G, Lambert GW, Jennings GL, Thompson J, Esler MD. Plasma norepinephrine responses to head-up tilt are misleading in autonomic failure. Hypertension 1992, 19:628-633.
23. van Mierlo LA, Koning MM, van der ZK, Draijer R. Lactotripeptides do not lower ambulatory blood pressure in untreated whites: results from 2 controlled multicenter crossover studies. Am J Clin Nutr 2009, 89:617-623.
24. Millar JA, Leckie BJ, Morton JJ, Jordan J, Tree M. A microassay for active and total renin concentration in human plasma based on antibody trapping. Clin Chim Acta 1980, 101:5-15.
25. Mizushima S, Ohshige K, Watanabe J, Kimura M, Kadowaki T, Nakamura Y, Tochikubo O, Ueshima H. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. Am J Hypertens 2004, 17:701-706.
26. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J Dairy Sci 1995, 78:777-783.
27. Nurminen ML, Sipola M, Kaarto H, Pihlanto-Leppala A, Piilola K, Korpela R, Tossavainen O, Korhonen H, Vapaatalo H. Alpha-lactorphin lowers blood pressure measured by radiotelemetry in normotensive and spontaneously hypertensive rats. Life Sci 2000, 66:1535-1543.
28. Ottesen MM, Worck R, Ibsen H. Captopril does not blunt the sympathoadrenal response to cigarette smoking in normotensive humans. Blood Press 1997, 6:29-34.
29. Seppo L, Jauhiainen T, Poussa T, Korpela R. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am J Clin Nutr 2003, 77:326-330.
30. Sipola M, Finckenberg P, Korpela R, Vapaatalo H, Nurminen ML. Effect of long-term intake of milk products on blood pressure in hypertensive rats. J Dairy Res 2002, 69:103-111.
31. Usinger L, Ibsen H, Jensen LT. Does fermented milk possess antihypertensive effect in humans? J Hypertens 2009, 27:1115-1120.
32. Wuerzner G, Peyrard S, Blanchard A, Lalanne F, Azizi M. The lactotripeptides isoleucine-proline-proline and valine-proline-proline do not inhibit the N-terminal or C-terminal angiotensin converting enzyme active sites in humans. J Hypertens 2009, 27:1404-1409.
33. Yamamoto N, Akino A, Takano T. Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J Dairy Sci 1994, 77:917-922.
34. Yamamoto M, Maeno M, Takano T. Purification and characterization of an antihypertensive peptide from a yoghurt-like product fermented by lactobacillus helveticus cpn4. J Dairy Sci 1999, 82:1388-1393.